Kolexia
Lambert-Niclot Sidonie
Pharmacien
Hôpital Saint-Antoine
Paris, France
118 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Virémie COVID-19 Séropositivité VIH Hépatite B chronique Effets secondaires indésirables des médicaments Sarcomes Sarcome de Kaposi Inflammation

Industries

Adliva
17 collaboration(s)
Dernière en 2021
KEPHREN PUBLISHING
8 collaboration(s)
Dernière en 2023
Gilead
6 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2023

Dernières activités

Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes.
The Journal of infectious diseases   11 janvier 2024
Dolutegravir/rilpivirine (DTG/RPV) therapy as a maintenance treatment in PLWH with past virological failures and resistance-associated mutations to NNRTIs and INSTIs
HIV medicine Congress 2023   01 décembre 2023
HIV viremias among patients who discontinued Cabotegravir (CAB)/Rilpivirine (RPV) Long acting (LA) intramuscular (IM) in real-life setting
HIV medicine Congress 2023   01 décembre 2023
ANRS 177 DUETTO randomized, open-label and multicentric trial evaluating the non-inferiority of maintenance antiretroviral dual therapy taken 4 consecutive days per week versus dual therapy 7/7 days per week
HIV medicine Congress 2023   01 décembre 2023
Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV.
BMC infectious diseases   04 septembre 2023
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
The Journal of antimicrobial chemotherapy   02 juin 2023
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   05 mai 2023
Prevalence of HIV-1 Natural Polymorphisms and Integrase-Resistance-Associated Mutations in African Children.
Viruses   16 février 2023
APOBEC-Induced Mutations at Initiation of Cabotegravir + Rilpivirine for Two Patients Infected by HIV-1 Subtype CRF02: The Interest of Systematic Genotyping.
Journal of acquired immune deficiency syndromes (1999)   15 février 2023
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study.
Journal of global antimicrobial resistance   07 août 2022